19.01.2016 • NewsSaudi AramcocompanyDede Willams

Saudi Aramco Confirms IPO is an Option

christian42 - Fotolia
christian42 - Fotolia

With falling oil prices making resource-rich Middle East countries nervous, some of them are looking for new sources of revenue to finance their burgeoning petrochemical empires. State-owned Saudi Aramco, world’s largest producer and exporter of crude, has now confirmed it is considering an initial public offering. Talk about an ipo was touched off early by an interview given by Saudi Deputy Crown Prince Mohammed bin Salman to the British magazine The Economist, A decision is expected to be made later this year.

In a statement, the company said it “has been studying various options to allow broad public participation in its equity,” either through a listing “of an appropriate percentage” of shares in its main company or the listing of a selected downstream subsidiaries.

Aramco said the launch proposal is “consistent with the broad and progressive direction pursued by the Saudi kingdom for reforms, including privatization in various sectors of the economy and deregulation of markets, which the company strongly supports.”

Speculating on the possible share price, stock market observers said the assets could be worth as much as $4.7 trillion, as Aramco’s oil assets alone are worth 10 times those held by the world’s largest publicly quoted oil company, ExxonMobil. The Texas group has a stock market value of $400 billion. Analysts told news agencies they expected the kingdom to make only a small stake available to the public.

Aramco controls 100 oil and gas fields, including Ghawar, the world’s largest onshore oil location, and Safaniya, the world’s biggest offshore field. As a partner in the Sadara joint venture with Dow Chemical, now coming on stream, it will also be a major producer of petrochemicals.

In early December 2015, Sadara announced the on-time start-up of the first of the site’s two LLDPE plants, using Dow’s Solution technology. When a similar-sized LLDPE plant goes on stream the complex will be able to produce 750,000 t/y of the commodity plastic.

The Dhahran complex also will include facilities for LDPE and PP as well as polyolefin elastomers – downstream of a multi-feed cracker with capacity for 1.5m t/y of ethylene and 400,000 t/y of propylene. A second-phase project will see the installation of capacity for the isocyanates MDI and TDI, along with polyols.

German chemical producer Lanxess recently presented the Saudi company as its partner in a 50:50 joint venture to produce synthetic rubber, which would have annual sales of €3 billion and an enterprise value of €2.75 billion. The as yet unnamed jv will be the world’s largest rubber producer.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.